Royalty Pharma maintained as Buy by TD Cowen
TD Cowen maintained its Buy rating on Royalty Pharma.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
TD Cowen maintained its Buy rating on Royalty Pharma.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.